Oak Ridge Investments LLC Has $2.32 Million Holdings in Iradimed Corporation (NASDAQ:IRMD)

Oak Ridge Investments LLC lowered its position in Iradimed Corporation (NASDAQ:IRMD) by 3.1% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 42,146 shares of the medical equipment provider’s stock after selling 1,353 shares during the period. Oak Ridge Investments LLC’s holdings in Iradimed were worth $2,318,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also modified their holdings of IRMD. Huntington National Bank raised its position in Iradimed by 51.3% in the 3rd quarter. Huntington National Bank now owns 1,487 shares of the medical equipment provider’s stock valued at $75,000 after purchasing an additional 504 shares during the last quarter. Gladius Capital Management LP raised its holdings in shares of Iradimed by 126.6% in the third quarter. Gladius Capital Management LP now owns 1,727 shares of the medical equipment provider’s stock valued at $87,000 after buying an additional 965 shares during the last quarter. Quantbot Technologies LP grew its holdings in Iradimed by 83.0% during the 3rd quarter. Quantbot Technologies LP now owns 2,320 shares of the medical equipment provider’s stock worth $117,000 after acquiring an additional 1,052 shares during the last quarter. Wilmington Savings Fund Society FSB acquired a new stake in Iradimed in the 3rd quarter valued at about $126,000. Finally, SG Americas Securities LLC acquired a new stake in Iradimed in the 3rd quarter valued at about $147,000. 92.34% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Iradimed

In related news, CFO John Glenn sold 2,500 shares of Iradimed stock in a transaction dated Monday, December 2nd. The stock was sold at an average price of $54.18, for a total value of $135,450.00. Following the completion of the sale, the chief financial officer now directly owns 4,383 shares in the company, valued at $237,470.94. This trade represents a 36.32 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 37.10% of the stock is currently owned by corporate insiders.

Iradimed Trading Up 1.4 %

Shares of IRMD stock opened at $59.17 on Friday. Iradimed Corporation has a 1 year low of $40.18 and a 1 year high of $59.31. The firm’s 50 day moving average is $54.76 and its 200-day moving average is $50.17. The firm has a market capitalization of $749.68 million, a price-to-earnings ratio of 40.53 and a beta of 0.81.

Iradimed Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, November 25th. Stockholders of record on Friday, November 15th were paid a $0.15 dividend. The ex-dividend date was Friday, November 15th. This represents a $0.60 annualized dividend and a dividend yield of 1.01%. Iradimed’s dividend payout ratio (DPR) is currently 41.10%.

About Iradimed

IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.